,i #aaith ,,congress #ast ,session ,h4 ,r4 #ffa ,,in ,,the ,,house ,,of ,,representatives ,january #bc1 #bjbe,mr4 ,buchanan 7for himself1 ,mr4 ,soto1 and ,mrs4 ,miller-,meeks7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to require the ,secretary of ,health and ,human ,services1 in consultation with the ,secretary of ,commerce1 the ,council for ,technology and ,innovation of the ,centers for ,medicare ,medicaid ,services1 and the ,commissioner of ,food and ,drugs1 to carry out a program to facilitate and coordinate efforts between the ,united ,states and ,israel to expand and enhance collaboration on the development and delivery of health care products and services4 #a4 ,short title ,this ,act may be cited as the ,maximizing ,israel-,u4,s4 ,research ,advancement and ,collaborative ,leadership in ,emerging ,medical ,technology ,act of #bjbe or the ,,miracle ,medical ,technology ,act of #bjbe4 #b4 ,program for facilitation and coordination of ,united ,states-,israel efforts on the development and delivery of health care products and services 7a7 ,in general ,subject to the availability of appropriations1 the ,secretary of ,health and ,human ,services1 in consultation with the ,secretary of ,commerce1 the ,council for ,technology and ,innovation of the ,centers for ,medicare ,medicaid ,services1 and the ,commissioner of ,food and ,drugs1 shall carry out a program to facilitate and coordinate efforts between the ,united ,states and ,israel to expand and enhance collaboration on-- 7#a7 the development of health care products and services2 and 7#b7 the delivery of such products and services to those in need4 7b7 ,program components ,the program under subsection 7a7 shall include facilitation and coordination of efforts including each of the following3 7#a7 ,research and development 7,a7 ,joint research projects between ,united ,states and ,israeli institutions and companies4 7,b7 ,promoting collaboration in areas such as medical device technology1 pharmaceuticals 7including biological products1 genomics1 and innovative digital health care solutions71 and health care systems management1 including a special focus on early-stage clinical trials4 7,c7 ,with respect to biological products1 supporting-- 7i7 innovation2 7ii7 process optimization2 and 7iii7 the development of advanced manufacturing techniques that can enhance productivity1 reduce costs1 and improve product quality4 7,d7 ,work toward developing a framework for sharing health data for research purposes with the ,ministry of ,health of ,israel4 7#b7 ,innovation and start-up ecosystem 7,a7 ,fostering collaboration between ,united ,states and ,israeli start-up and other companies in the health care sector4 7,b7 ,facilitating innovative technology acceptance by the marketplace4 7,c7 ,facilitating mechanisms for technology transfer and joint venture opportunities4 7,d7 ,supporting innovation hubs to accelerate the development and commercialization of ,united ,states health care technologies in the ,israeli market1 including by encouraging cybersecurity standards for sharing data1 promoting patient privacy1 and encouraging research4 7#c7 ,regulatory harmonization and intellectual property protection ,establishing joint efforts-- 7,a7 to ensure intellectual property protection2 7,b7 to increase regulatory harmonization1 including with respect to regulatory data protection for biological products2 7,c7 to formulate plans for a commercialization framework for medical device technologies2 7,d7 to encourage a potential mutual recognition agreement for pharmaceutical good manufacturing ,practices between the ,food and ,drug ,administration and ,israeli regulators2 7,e7 to strengthen and reaffirm the confidentiality commitment with the ,food and ,drug ,administration and the ,pharmaceutical ,division1 the ,medical ,devices ,department1 and the ,national ,food ,services and ,nutrition ,division of the ,ministry of ,health of ,israel2 7,f7 to encourage ,israel's participation in regulatory harmonization and cooperation organizations2 and 7,g7 to expand international collaboration under ,project ,orbis for concurrent submission and review of oncology products4 7#d7 ,health care system strengthening ,facilitating the sharing of best practices1 knowledge1 and skills in areas such as clinical care and health care management4 7#e7 ,telemedicine and digital health cooperation ,establishing initiatives-- 7,a7 to enhance telemedicine infrastructure2 7,b7 to promote interoperability between ,united ,states and ,israeli health care systems2 and 7,c7 to facilitate collaboration on digital health technologies1 data analytics1 and cybersecurity4 7#f7 ,disease prevention initiatives ,collaborating in disease prevention1 including joint efforts to combat infectious diseases1 develop vaccines1 and share epidemiological data4 7#g7 ,biological product manufacturing 7,a7 ,promoting biological product manufacturing4 7,b7 ,establishing joint manufacturing facilities for biological products in facilities in the ,united ,states that leverage the strengths and expertise of both countries4 7,c7 ,pursuing accelerated development of life-saving treatments and new sources of nutrition that are both healthier and more available at an affordable cost4 7,d7 ,workforce training and skill development1 including promoting exchange programs and training initiatives to develop a skilled workforce in biological product manufacturing4 7,e7 ,supply chain resilience through strategic collaboration to identify and develop contingency plans to mitigate biological product supply disruptions4 7,f7 ,facilitating public-private partnerships to support the development and scale-up of biological product manufacturing capabilities4 7c7 ,united ,states-,israel ,health ,care ,collaboration ,center ,in carrying out the program under subsection 7a71 the ,secretary of ,health and ,human ,services may establish a joint ,united ,states-,israel ,health ,care ,collaboration ,center in the ,united ,states leveraging the experience1 knowledge1 and expertise of institutions of higher education1 national laboratories1 entities in the private sector1 and others in the development and delivery of health care products and services4 7d7 ,commencement of implementation ,not later than #f months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall commence implementation of the program under this section4 7e7 ,authorization of appropriations ,to carry out this ,act1 there is authorized to be appropriated #h1jjj1jjj for each of fiscal years #bjbf through #bjcj4